Bank of New York Mellon’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.4M | Buy |
|
|||||
|
2025
Q1 | $18.2M | Sell |
|
|||||
|
2024
Q4 | $15.1M | Buy |
|
|||||
|
2024
Q3 | $16M | Buy |
|
|||||
|
2024
Q2 | $7.08M | Buy |
|
|||||
|
2024
Q1 | $5.42M | Sell |
|
|||||
|
2023
Q4 | $4.66M | Buy |
|
|||||
|
2023
Q3 | $3.36M | Buy |
|
|||||
|
2023
Q2 | $5.51M | Buy |
|
|||||
|
2023
Q1 | $3.88M | Buy |
|
|||||
|
2022
Q4 | $1.79M | Buy |
|
|||||
|
2022
Q3 | $1.33M | Buy |
|
|||||
|
2022
Q2 | $1.12M | Buy |
|
|||||
|
2022
Q1 | $3.31M | Buy |
|
|||||
|
2021
Q4 | $4.74M | Buy |
|
|||||
|
2021
Q3 | $2.32M | Sell |
|
|||||
|
2021
Q2 | $6.57M | Buy |
|
|||||
|
2021
Q1 | $3.46M | Buy |
|
|||||
|
2020
Q4 | $2.61M | Buy |
|
|||||
|
2020
Q3 | $1.85M | Sell |
|
|||||
|
2020
Q2 | $1.79M | Buy |
|
|||||
|
2020
Q1 | $590K | Buy |
|
|||||
|
2019
Q4 | $589K | Buy |
|
|||||
|
2019
Q3 | $930K | Sell |
|
|||||
|
2019
Q2 | $1.26M | Buy |
|
|||||
|
2019
Q1 | $792K | Sell |
|
|||||
|
2018
Q4 | $426K | Hold |
|
|||||
|
2018
Q3 | $651K | Hold |
|
|||||
|
2018
Q2 | $426K | Buy |
|
|||||
|
2018
Q1 | $430K | Buy |
|
|||||
|
2017
Q4 | $925K | Buy |
|
|||||
|
2017
Q3 | $513K | Buy |
|
|||||
|
2017
Q2 | $313K | Buy |
|
|||||
|
2017
Q1 | $335K | Buy |
|
|||||
|
2016
Q4 | $500K | Buy |
|
|||||
|
2016
Q3 | $301K | Buy |
|